These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 32909060)

  • 1. Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered.
    Saussez S; Lechien JR; Hopkins C
    Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2187-2191. PubMed ID: 32909060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological relationship between COVID-19 and olfactory dysfunction: A systematic review.
    Las Casas Lima MH; Cavalcante ALB; Leão SC
    Braz J Otorhinolaryngol; 2022; 88(5):794-802. PubMed ID: 33965353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments.
    Najafloo R; Majidi J; Asghari A; Aleemardani M; Kamrava SK; Simorgh S; Seifalian A; Bagher Z; Seifalian AM
    ACS Chem Neurosci; 2021 Oct; 12(20):3795-3805. PubMed ID: 34609841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection of sustentacular cells disrupts olfactory signaling pathways.
    Verma AK; Zheng J; Meyerholz DK; Perlman S
    JCI Insight; 2022 Dec; 7(24):. PubMed ID: 36378534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism.
    Bilinska K; Butowt R
    ACS Chem Neurosci; 2020 Aug; 11(15):2152-2155. PubMed ID: 32673476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Molecular Basis of Olfactory Dysfunction in COVID-19 and Long COVID.
    Anastassopoulou C; Davaris N; Ferous S; Siafakas N; Boufidou F; Anagnostopoulos K; Tsakris A
    Lifestyle Genom; 2024; 17(1):42-56. PubMed ID: 38749402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework.
    Shahbaz MA; De Bernardi F; Alatalo A; Sachana M; Clerbaux LA; Muñoz A; Parvatam S; Landesmann B; Kanninen KM; Coecke S
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The alleged mechanisms of olfactory disorders in the new coronavirus infection].
    Lashch NY; Yunyaev AR; Evsyukova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(2):7-11. PubMed ID: 36843453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory training for olfactory dysfunction in COVID-19: A promising mitigation amidst looming neurocognitive sequelae of the pandemic.
    Ojha P; Dixit A
    Clin Exp Pharmacol Physiol; 2022 Apr; 49(4):462-473. PubMed ID: 35090056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A primer on viral-associated olfactory loss in the era of COVID-19.
    Soler ZM; Patel ZM; Turner JH; Holbrook EH
    Int Forum Allergy Rhinol; 2020 Jul; 10(7):814-820. PubMed ID: 32271490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival.
    Hopkins C; Lechien JR; Saussez S
    Med Hypotheses; 2021 Jan; 146():110406. PubMed ID: 33246692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms.
    Butowt R; Bilinska K; von Bartheld CS
    Trends Neurosci; 2023 Jan; 46(1):75-90. PubMed ID: 36470705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and olfactory dysfunction: a looming wave of dementia?
    Kay LM
    J Neurophysiol; 2022 Aug; 128(2):436-444. PubMed ID: 35894511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb.
    Khan M; Yoo SJ; Clijsters M; Backaert W; Vanstapel A; Speleman K; Lietaer C; Choi S; Hether TD; Marcelis L; Nam A; Pan L; Reeves JW; Van Bulck P; Zhou H; Bourgeois M; Debaveye Y; De Munter P; Gunst J; Jorissen M; Lagrou K; Lorent N; Neyrinck A; Peetermans M; Thal DR; Vandenbriele C; Wauters J; Mombaerts P; Van Gerven L
    Cell; 2021 Nov; 184(24):5932-5949.e15. PubMed ID: 34798069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic.
    Liu DT; Prem B; Besser G; Renner B; Mueller CA
    Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Olfactory dysfunction and COVID-19 - current state of the problem].
    Karapetyan LS; Svistushkin VM
    Vestn Otorinolaringol; 2020; 85(6):100-104. PubMed ID: 33474926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Loss of smell, a preliminary indicator of COVID-19].
    Waizel-Haiat S; Waizel-Bucay J
    Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):4-6. PubMed ID: 33666408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent post-COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium.
    Finlay JB; Brann DH; Abi Hachem R; Jang DW; Oliva AD; Ko T; Gupta R; Wellford SA; Moseman EA; Jang SS; Yan CH; Matsunami H; Tsukahara T; Datta SR; Goldstein BJ
    Sci Transl Med; 2022 Dec; 14(676):eadd0484. PubMed ID: 36542694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.
    Speth MM; Singer-Cornelius T; Oberle M; Gengler I; Brockmeier SJ; Sedaghat AR
    Otolaryngol Head Neck Surg; 2020 Jul; 163(1):114-120. PubMed ID: 32423357
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 39.